Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

Dysregulation of the complement system in immune thrombocytopenia

View Full Paper
Ask AI
Bookmark
Share

Authors

NVNóra Veszeli

Discussion

Loading...

Member takes

Overview

Randomised trials show distinct complement profiles in immune thrombocytopenia patients, suggesting new therapeutic targets.

Key Points

  • Investigate the role of the complement system in immune thrombocytopenia and its variations across disease phases.
  • Compared complement biomarker profiles between acute and chronic ITP patients and healthy controls.
  • Analyzed levels of complement activation markers using ELISA.
  • Applied statistical tests to assess differences in biomarker levels among groups.
  • ITP patients showed significant differences in complement markers compared to healthy controls.
  • Chronic ITP patients exhibited significantly elevated C1s-C1-inhibitor levels compared to acute patients.
  • Key complement markers indicated distinct pathophysiological mechanisms in ITP phases.

Cite This Study

Nóra Veszeli (2025) studied this question.

synapsesocial.com/papers/69362f6e4fa91c937236e121https://doi.org/10.1182/blood-2025-4823
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complement activation profile in adult primary immune thrombocytopenia2026 · 2 citations
  2. 2Complement activation and its pathways in primary immune thrombocytopenia2026
  3. 3Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes2025
  4. 4Platelet dysfunction in immune thrombocytopenia: Finding clinical subsets with platelet phenotypes2025 · 3 citations
  5. 5Flow cytometric analysis of T-cell subsets and platelet surface markers in patients with immune thrombocytopenia: a case-control study2026